These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29917241)

  • 21. GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
    Vance KM; Hansen KB; Traynelis SF
    J Physiol; 2012 Aug; 590(16):3857-75. PubMed ID: 22641781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.
    Yi F; Bhattacharya S; Thompson CM; Traynelis SF; Hansen KB
    J Physiol; 2019 Nov; 597(22):5495-5514. PubMed ID: 31541561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular bases of NMDA receptor subtype-dependent properties.
    Glasgow NG; Siegler Retchless B; Johnson JW
    J Physiol; 2015 Jan; 593(1):83-95. PubMed ID: 25556790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent roles of a peripheral transmembrane segment in AMPA and NMDA receptors.
    Amin JB; Salussolia CL; Chan K; Regan MC; Dai J; Zhou HX; Furukawa H; Bowen ME; Wollmuth LP
    J Gen Physiol; 2017 Jun; 149(6):661-680. PubMed ID: 28507080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs.
    Chou TH; Kang H; Simorowski N; Traynelis SF; Furukawa H
    Mol Cell; 2022 Dec; 82(23):4548-4563.e4. PubMed ID: 36309015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of M4 Transmembrane Segments in NMDA Receptor Function: A Negative Allosteric Modulatory Site at the GluN1 M4 is Determining the Efficiency of Neurosteroid Modulation.
    Langer K; Müller-Längle A; Wempe J; Laube B
    Front Pharmacol; 2021; 12():769046. PubMed ID: 34658899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
    Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asynchronous movements prior to pore opening in NMDA receptors.
    Kazi R; Gan Q; Talukder I; Markowitz M; Salussolia CL; Wollmuth LP
    J Neurosci; 2013 Jul; 33(29):12052-66. PubMed ID: 23864691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-channel properties of N-methyl-D-aspartate receptors containing chimaeric GluN2A/GluN2D subunits.
    O'Leary T; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1347-54. PubMed ID: 19909274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic contributions to gating by interactions unique to N-methyl-D-aspartate (NMDA) receptors.
    Borschel WF; Cummings KA; Tindell LK; Popescu GK
    J Biol Chem; 2015 Oct; 290(44):26846-55. PubMed ID: 26370091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction.
    Siegler Retchless B; Gao W; Johnson JW
    Nat Neurosci; 2012 Jan; 15(3):406-13, S1-2. PubMed ID: 22246434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
    Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
    J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain.
    Zhu S; Stroebel D; Yao CA; Taly A; Paoletti P
    Nat Struct Mol Biol; 2013 Apr; 20(4):477-85. PubMed ID: 23454977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water.
    Mesbahi-Vasey S; Veras L; Yonkunas M; Johnson JW; Kurnikova MG
    PLoS One; 2017; 12(6):e0177686. PubMed ID: 28582391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
    Hansen KB; Tajima N; Risgaard R; Perszyk RE; Jørgensen L; Vance KM; Ogden KK; Clausen RP; Furukawa H; Traynelis SF
    Mol Pharmacol; 2013 Jul; 84(1):114-27. PubMed ID: 23625947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of ArgTX-636 in the NMDA receptor ion channel.
    Poulsen MH; Andersen J; Christensen R; Hansen KB; Traynelis SF; Strømgaard K; Kristensen AS
    J Mol Biol; 2015 Jan; 427(1):176-89. PubMed ID: 24862283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational rearrangement of the NMDA receptor amino-terminal domain during activation and allosteric modulation.
    Vyklicky V; Stanley C; Habrian C; Isacoff EY
    Nat Commun; 2021 May; 12(1):2694. PubMed ID: 33976221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Evaluation of a De Novo
    Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
    Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of NMDA receptor functional diversity.
    Paoletti P
    Eur J Neurosci; 2011 Apr; 33(8):1351-65. PubMed ID: 21395862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.